XML 21 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Equity Investment
3 Months Ended
Mar. 31, 2017
Notes to Financial Statements  
Equity Method Investments and Joint Ventures Disclosure [Text Block]
 
3
.
Equity Investment
 
Mission Providence
 
The Company entered into a joint venture agreement in
November
2014
to form Mission Providence Pty Ltd (“Mission Providence”). Mission Providence delivers employment preparation and placement services in Australia. The Company has a
60%
ownership interest in Mission Providence, and has rights to
75%
of Mission Providence’s distributions of cash or profit surplus twice per calendar year.
 
The Company determined it has a variable interest in Mission Providence. However, it does not have unilateral power to direct the activities that most significantly impact Mission Providence’s economic performance, which include budget approval, business planning, the appointment of key officers and liquidation and distribution of share capital. As a result, the Company is not the primary beneficiary of Mission Providence. The Company accounts for this investment under the equity method of accounting and the Company’s share of Mission Providence’s losses are recorded as “Equity in net loss of investees” in the accompanying condensed consolidated statements of income. Cash contributions made to Mission Providence in exchange for its equity interests are included in the condensed consolidated statements of cash flows as “Equity investments.”
 
The following table summarizes the carrying amounts of the assets and liabilities included in the Company’s consolidated balance sheet and the maximum loss exposure related to the Company’s interest in Mission Providence as of
March
31,
2017
and
December
31,
2016:
 
 
 
Equity
Investments
 
 
Other
Assets
 
 
Accrued
Expenses
 
 
Maximum
Exposure to
Loss
 
March 31, 2017
  $
2,868
    $
573
    $
-
    $
3,441
 
December 31, 2016
  $
4,021
    $
-
    $
-
    $
4,021
 
 
Other assets represent a loan to Mission Providence, which was made during the
three
months ended
March
31,
2017.
Summary financial information for Mission Providence on a standalone basis is as follows:
 
 
 
 
March 31, 2017
 
 
December 31, 2016
 
Current assets
  $
756
    $
4,640
 
Long-term assets
   
10,867
     
10,473
 
Current liabilities
   
12,186
     
12,844
 
Long-term liabilities
   
-
     
1,655
 
 
 
 
Three months ended
March 31, 2017
 
 
Three months ended
March 31, 2016
 
Revenue
  $
9,388
    $
7,418
 
Operating loss
   
(1,150
)    
(4,428
)
Net loss
   
(1,203
)    
(2,974
)
 
During the
three
months ended
March
31,
2017,
Mission Providence recorded restructuring and redundancy costs of
$1,063.
 
Matrix
 
Prior to the closing of the Matrix Transaction on
October
19,
2016,
the financial results of Matrix were included in the Company’s HA Services segment. Subsequent to the closing of the Matrix Transaction, the Company owns a noncontrolling interest in Matrix. Pursuant to a Shareholder’s Agreement, affiliates of Frazier Healthcare Partners hold rights necessary to control the fundamental operations of Matrix. The Company accounts for this investment in Matrix under the equity method of accounting and the Company’s share of Matrix’s losses are recorded as “Equity in net loss of investees” in the accompanying condensed consolidated statements of income.
 
The carrying amount of the assets included in the Company’s condensed consolidated balance sheet and the maximum loss exposure related to the Company’s interest in Matrix as of
March
31,
2017
and
December
31,
2016
totaled
$156,355
and
$157,202,
respectively.
 
Summary financial information for Matrix on a standalone basis is as follows:
 
 
 
March 31, 2017
 
 
December 31, 2016
 
Current assets
  $
35,899
    $
28,589
 
Long-term assets
   
609,429
     
614,841
 
Current liabilities
   
31,198
     
25,791
 
Long-term liabilities
   
227,953
     
281,348
 
 
 
 
Three months ended
March 31, 2017
 
Revenue
  $
55,855
 
Operating income
   
1,008
 
Net loss
   
(1,857
)
 
Included in Matrix’s net loss are transaction bonuses and other transaction related costs of
$2,994,
equity compensation of
$643,
depreciation and amortization of
$8,033
and interest expense of
$3,607.